| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 ARHGAP32 RANBP2 RGPD8 RGPD1 ARFGEF1 ARHGAP39 SYNGAP1 EVI5 NF1 RASGRP3 RGPD3 GNB5 RGPD5 | 2.15e-09 | 279 | 124 | 14 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 ARHGAP32 RANBP2 RGPD8 DOCK11 OBSCN RGPD1 ARFGEF2 ARFGEF1 ARHGAP39 SYNGAP1 EVI5 NF1 RASGRP3 RGPD3 GNB5 RGL2 RGPD5 | 2.44e-09 | 507 | 124 | 18 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 ARHGAP32 RANBP2 RGPD8 DOCK11 OBSCN RGPD1 ARFGEF2 ARFGEF1 ARHGAP39 SYNGAP1 EVI5 NF1 RASGRP3 RGPD3 GNB5 RGL2 RGPD5 | 2.44e-09 | 507 | 124 | 18 | GO:0030695 |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.23e-07 | 20 | 124 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.75e-06 | 36 | 124 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 ARHGAP32 RANBP2 RGPD8 RGPD1 ARFGEF1 ARHGAP39 SYNGAP1 EVI5 NF1 RASGRP3 RGPD3 GNB5 ALK RGPD5 | 1.39e-05 | 656 | 124 | 15 | GO:0008047 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.44e-05 | 50 | 124 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 RANBP2 DMXL2 RGPD8 DOCK11 POT1 RGPD1 EVI5 RASGRP3 RGPD3 GNB3 | 1.54e-05 | 360 | 124 | 11 | GO:0051020 |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 ARHGAP32 RANBP2 CPAMD8 RGPD8 KDM5A DOCK11 POT1 OBSCN RGPD1 ARFGEF2 ARFGEF1 ARHGAP39 SYNGAP1 EVI5 NF1 RASGRP3 RGPD3 GNB5 SMO RGL2 ALK RGPD5 | 1.87e-05 | 1418 | 124 | 23 | GO:0030234 |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.93e-05 | 53 | 124 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 3.00e-05 | 58 | 124 | 5 | GO:0051018 | |
| GeneOntologyMolecularFunction | small GTPase binding | RGPD4 RANBP2 DMXL2 RGPD8 DOCK11 POT1 RGPD1 EVI5 RASGRP3 RGPD3 | 3.24e-05 | 321 | 124 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | tRNA-4-demethylwyosine synthase activity | 3.83e-05 | 2 | 124 | 2 | GO:0102521 | |
| GeneOntologyMolecularFunction | glutathione transmembrane transporter activity | 7.87e-04 | 7 | 124 | 2 | GO:0034634 | |
| GeneOntologyMolecularFunction | oxo-acid-lyase activity | 7.87e-04 | 7 | 124 | 2 | GO:0016833 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 1.11e-03 | 33 | 124 | 3 | GO:0072349 | |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 1.34e-03 | 9 | 124 | 2 | GO:0042937 | |
| GeneOntologyMolecularFunction | myosin binding | 1.95e-03 | 85 | 124 | 4 | GO:0017022 | |
| GeneOntologyMolecularFunction | G-rich strand telomeric DNA binding | 2.03e-03 | 11 | 124 | 2 | GO:0098505 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 8.59e-10 | 9 | 123 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.44e-09 | 20 | 123 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.71e-09 | 10 | 123 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 8.61e-09 | 13 | 123 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.33e-08 | 14 | 123 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 2.98e-06 | 38 | 123 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 1.74e-05 | 54 | 123 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | SPRY3 ARHGAP32 DOCK11 OBSCN ARFGEF2 ARFGEF1 ARHGAP39 ITGA3 EDNRA SYNGAP1 NF1 RASGRP3 RGL2 | 2.01e-05 | 538 | 123 | 13 | GO:0007264 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.25e-05 | 195 | 123 | 8 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 2.80e-05 | 201 | 123 | 8 | GO:0051170 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | SPRY3 ARHGAP32 OBSCN ARFGEF2 ARFGEF1 ARHGAP39 ITGA3 SYNGAP1 NF1 RGL2 | 3.14e-05 | 333 | 123 | 10 | GO:0051056 |
| GeneOntologyBiologicalProcess | protection from non-homologous end joining at telomere | 3.30e-05 | 11 | 123 | 3 | GO:0031848 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 6.61e-05 | 71 | 123 | 5 | GO:0006111 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination at telomere | 1.05e-04 | 3 | 123 | 2 | GO:0072695 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA recombination at telomere | 1.05e-04 | 3 | 123 | 2 | GO:0048239 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 1.53e-04 | 134 | 123 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 3.25e-04 | 362 | 123 | 9 | GO:0034504 | |
| GeneOntologyBiologicalProcess | telomeric loop formation | 3.49e-04 | 5 | 123 | 2 | GO:0031627 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 3.44e-10 | 8 | 122 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.53e-09 | 10 | 122 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.20e-08 | 14 | 122 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 5.03e-08 | 18 | 122 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 9.01e-08 | 20 | 122 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.18e-07 | 21 | 122 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore | 2.82e-05 | 101 | 122 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | inclusion body | 1.84e-04 | 90 | 122 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear membrane | 2.12e-04 | 349 | 122 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 4.06e-04 | 25 | 122 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | shelterin complex | 6.96e-04 | 7 | 122 | 2 | GO:0070187 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 1.11e-03 | 35 | 122 | 3 | GO:0005834 | |
| GeneOntologyCellularComponent | axoneme | 1.37e-03 | 207 | 122 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.40e-03 | 208 | 122 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.47e-03 | 10 | 122 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 RANBP2 RGPD8 RGPD1 EDNRA RGPD3 NAV3 ANKRD17 TMEM109 RGPD5 | 1.66e-03 | 560 | 122 | 10 | GO:0005635 |
| GeneOntologyCellularComponent | GTPase complex | 1.76e-03 | 41 | 122 | 3 | GO:1905360 | |
| GeneOntologyCellularComponent | nuclear telomere cap complex | 2.53e-03 | 13 | 122 | 2 | GO:0000783 | |
| GeneOntologyCellularComponent | telomere cap complex | 2.53e-03 | 13 | 122 | 2 | GO:0000782 | |
| GeneOntologyCellularComponent | chylomicron | 2.53e-03 | 13 | 122 | 2 | GO:0042627 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 5.96e-08 | 16 | 97 | 5 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 8.50e-07 | 26 | 97 | 5 | MP:0012058 | |
| MousePheno | increased lung carcinoma incidence | 1.10e-06 | 78 | 97 | 7 | MP:0008714 | |
| MousePheno | decreased tumor latency | 1.80e-06 | 30 | 97 | 5 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 2.14e-06 | 31 | 97 | 5 | MP:0012129 | |
| MousePheno | abnormal chromosome morphology | 2.57e-06 | 126 | 97 | 8 | MP:0003702 | |
| MousePheno | abnormal tumor latency | 3.44e-06 | 34 | 97 | 5 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 6.93e-06 | 39 | 97 | 5 | MP:0012128 | |
| MousePheno | increased respiratory system tumor incidence | 9.22e-06 | 107 | 97 | 7 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 9.22e-06 | 107 | 97 | 7 | MP:0008014 | |
| MousePheno | increased hepatobiliary system tumor incidence | 1.17e-05 | 111 | 97 | 7 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 1.17e-05 | 111 | 97 | 7 | MP:0008019 | |
| MousePheno | abnormal rod electrophysiology | 1.85e-05 | 119 | 97 | 7 | MP:0004021 | |
| MousePheno | abnormal chromosome number | 2.87e-05 | 86 | 97 | 6 | MP:0004023 | |
| MousePheno | abnormal cell nucleus morphology | 4.12e-05 | 184 | 97 | 8 | MP:0003111 | |
| MousePheno | aneuploidy | 6.34e-05 | 61 | 97 | 5 | MP:0004024 | |
| MousePheno | enlarged epididymis | 6.36e-05 | 99 | 97 | 6 | MP:0004931 | |
| MousePheno | increased sarcoma incidence | 7.52e-05 | 102 | 97 | 6 | MP:0002032 | |
| MousePheno | increased hepatocellular carcinoma incidence | 1.23e-04 | 70 | 97 | 5 | MP:0003331 | |
| MousePheno | abnormal eye electrophysiology | 1.84e-04 | 228 | 97 | 8 | MP:0005551 | |
| MousePheno | abnormal mitosis | 2.62e-04 | 128 | 97 | 6 | MP:0004046 | |
| MousePheno | increased carcinoma incidence | 4.37e-04 | 197 | 97 | 7 | MP:0002038 | |
| Domain | Ran_BP1 | 6.14e-11 | 12 | 122 | 6 | PF00638 | |
| Domain | RANBD1 | 6.14e-11 | 12 | 122 | 6 | PS50196 | |
| Domain | RanBD | 1.13e-10 | 13 | 122 | 6 | SM00160 | |
| Domain | Ran_bind_dom | 1.13e-10 | 13 | 122 | 6 | IPR000156 | |
| Domain | Grip | 4.90e-09 | 11 | 122 | 5 | SM00755 | |
| Domain | GRIP | 4.90e-09 | 11 | 122 | 5 | PF01465 | |
| Domain | GRIP_dom | 8.36e-09 | 12 | 122 | 5 | IPR000237 | |
| Domain | GRIP | 8.36e-09 | 12 | 122 | 5 | PS50913 | |
| Domain | Rab_bind | 5.97e-08 | 7 | 122 | 4 | PF16704 | |
| Domain | GCC2_Rab_bind | 5.97e-08 | 7 | 122 | 4 | IPR032023 | |
| Domain | WD40 | DMXL2 EML6 WDR46 EDC4 WDR76 DNAI3 DNAI1 EML5 GNB5 GNB4 LRBA GNB3 | 1.91e-07 | 268 | 122 | 12 | SM00320 |
| Domain | WD40_repeat | DMXL2 EML6 WDR46 EDC4 WDR76 DNAI3 DNAI1 EML5 GNB5 GNB4 LRBA GNB3 | 2.24e-07 | 272 | 122 | 12 | IPR001680 |
| Domain | WD_REPEATS_1 | DMXL2 EML6 WDR46 EDC4 WDR76 DNAI3 DNAI1 EML5 GNB5 GNB4 LRBA GNB3 | 2.83e-07 | 278 | 122 | 12 | PS00678 |
| Domain | WD_REPEATS_2 | DMXL2 EML6 WDR46 EDC4 WDR76 DNAI3 DNAI1 EML5 GNB5 GNB4 LRBA GNB3 | 2.94e-07 | 279 | 122 | 12 | PS50082 |
| Domain | WD_REPEATS_REGION | DMXL2 EML6 WDR46 EDC4 WDR76 DNAI3 DNAI1 EML5 GNB5 GNB4 LRBA GNB3 | 2.94e-07 | 279 | 122 | 12 | PS50294 |
| Domain | - | 3.53e-07 | 10 | 122 | 4 | 1.10.220.60 | |
| Domain | WD40_repeat_dom | DMXL2 EML6 WDR46 EDC4 WDR76 DNAI3 DNAI1 EML5 GNB5 GNB4 LRBA GNB3 | 5.73e-07 | 297 | 122 | 12 | IPR017986 |
| Domain | WD40 | 1.07e-06 | 259 | 122 | 11 | PF00400 | |
| Domain | - | DMXL2 EML6 WDR46 EDC4 WDR76 DNAI3 DNAI1 EML5 GNB5 GNB4 LRBA GNB3 | 1.90e-06 | 333 | 122 | 12 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | DMXL2 EML6 WDR46 EDC4 WDR76 DNAI3 DNAI1 EML5 GNB5 GNB4 LRBA GNB3 | 2.02e-06 | 335 | 122 | 12 | IPR015943 |
| Domain | Guanine_nucleotide-bd_bsu | 2.69e-06 | 5 | 122 | 3 | IPR016346 | |
| Domain | PH_dom-like | RGPD4 RANBP2 RGPD8 DOCK11 OBSCN RGPD1 SYNGAP1 MTMR4 CADPS RGPD3 LRBA RGPD5 | 2.29e-05 | 426 | 122 | 12 | IPR011993 |
| Domain | Gprotein_B | 3.16e-05 | 10 | 122 | 3 | IPR001632 | |
| Domain | Factor_5/8 | 4.23e-05 | 2 | 122 | 2 | IPR024715 | |
| Domain | tRNA_wybutosine-synth | 4.23e-05 | 2 | 122 | 2 | IPR013917 | |
| Domain | Wyosine_form | 4.23e-05 | 2 | 122 | 2 | PF08608 | |
| Domain | TPR-contain_dom | 5.80e-05 | 150 | 122 | 7 | IPR013026 | |
| Domain | TPR_REGION | 1.06e-04 | 165 | 122 | 7 | PS50293 | |
| Domain | TPR | 1.06e-04 | 165 | 122 | 7 | PS50005 | |
| Domain | - | RGPD4 RANBP2 RGPD8 DOCK11 OBSCN RGPD1 SYNGAP1 MTMR4 CADPS RGPD3 | 2.48e-04 | 391 | 122 | 10 | 2.30.29.30 |
| Domain | DCB_dom | 2.52e-04 | 4 | 122 | 2 | IPR032629 | |
| Domain | Sec7_C | 2.52e-04 | 4 | 122 | 2 | IPR015403 | |
| Domain | DUF1981 | 2.52e-04 | 4 | 122 | 2 | PF09324 | |
| Domain | Sec7_N | 2.52e-04 | 4 | 122 | 2 | IPR032691 | |
| Domain | Sec7_N | 2.52e-04 | 4 | 122 | 2 | PF12783 | |
| Domain | DCB | 2.52e-04 | 4 | 122 | 2 | PF16213 | |
| Domain | FA58C | 3.32e-04 | 21 | 122 | 3 | SM00231 | |
| Domain | FA58C_3 | 3.32e-04 | 21 | 122 | 3 | PS50022 | |
| Domain | FA58C_1 | 3.32e-04 | 21 | 122 | 3 | PS01285 | |
| Domain | FA58C_2 | 3.32e-04 | 21 | 122 | 3 | PS01286 | |
| Domain | Cu-oxidase_3 | 4.18e-04 | 5 | 122 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 4.18e-04 | 5 | 122 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 4.18e-04 | 5 | 122 | 2 | IPR033138 | |
| Domain | Cu-oxidase_3 | 4.18e-04 | 5 | 122 | 2 | PF07732 | |
| Domain | F5_F8_type_C | 4.98e-04 | 24 | 122 | 3 | PF00754 | |
| Domain | FA58C | 4.98e-04 | 24 | 122 | 3 | IPR000421 | |
| Domain | HELP | 6.24e-04 | 6 | 122 | 2 | PF03451 | |
| Domain | Cu_oxidase_Cu_BS | 6.24e-04 | 6 | 122 | 2 | IPR002355 | |
| Domain | HELP | 6.24e-04 | 6 | 122 | 2 | IPR005108 | |
| Domain | GPCR_2_secretin-like | 6.37e-04 | 60 | 122 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 6.37e-04 | 60 | 122 | 4 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 6.78e-04 | 61 | 122 | 4 | PS50261 | |
| Domain | fn3 | 6.85e-04 | 162 | 122 | 6 | PF00041 | |
| Domain | TPR-like_helical_dom | 8.54e-04 | 233 | 122 | 7 | IPR011990 | |
| Domain | Flavodoxin/NO_synth | 1.15e-03 | 8 | 122 | 2 | IPR008254 | |
| Domain | Flavdoxin-like | 1.15e-03 | 8 | 122 | 2 | IPR001094 | |
| Domain | FLAVODOXIN_LIKE | 1.15e-03 | 8 | 122 | 2 | PS50902 | |
| Domain | Flavodoxin_1 | 1.15e-03 | 8 | 122 | 2 | PF00258 | |
| Domain | - | 1.33e-03 | 73 | 122 | 4 | 2.60.120.260 | |
| Domain | FN3 | 1.36e-03 | 185 | 122 | 6 | SM00060 | |
| Domain | GPS | 1.40e-03 | 34 | 122 | 3 | SM00303 | |
| Domain | rSAM | 1.48e-03 | 9 | 122 | 2 | IPR007197 | |
| Domain | Radical_SAM | 1.48e-03 | 9 | 122 | 2 | PF04055 | |
| Domain | GPS | 1.53e-03 | 35 | 122 | 3 | PF01825 | |
| Domain | TPR | 1.58e-03 | 129 | 122 | 5 | SM00028 | |
| Domain | GPS | 1.66e-03 | 36 | 122 | 3 | PS50221 | |
| Domain | GPS | 1.80e-03 | 37 | 122 | 3 | IPR000203 | |
| Domain | TPR_repeat | 1.81e-03 | 133 | 122 | 5 | IPR019734 | |
| Domain | - | 1.84e-03 | 10 | 122 | 2 | 3.40.50.360 | |
| Domain | Flavoprotein-like_dom | 1.84e-03 | 10 | 122 | 2 | IPR029039 | |
| Domain | FN3 | 1.97e-03 | 199 | 122 | 6 | PS50853 | |
| Domain | Leu-rich_rpt | 2.03e-03 | 271 | 122 | 7 | IPR001611 | |
| Domain | - | 2.40e-03 | 207 | 122 | 6 | 1.25.40.10 | |
| Domain | FN3_dom | 2.52e-03 | 209 | 122 | 6 | IPR003961 | |
| Domain | Rho_GTPase_activation_prot | 2.65e-03 | 88 | 122 | 4 | IPR008936 | |
| Domain | Znf_FYVE_PHD | 2.80e-03 | 147 | 122 | 5 | IPR011011 | |
| Domain | TPR_1 | 2.87e-03 | 90 | 122 | 4 | IPR001440 | |
| Domain | TPR_1 | 2.87e-03 | 90 | 122 | 4 | PF00515 | |
| Domain | Galactose-bd-like | 3.36e-03 | 94 | 122 | 4 | IPR008979 | |
| Domain | RasGAP | 3.66e-03 | 14 | 122 | 2 | SM00323 | |
| Domain | - | 3.66e-03 | 14 | 122 | 2 | 2.60.40.420 | |
| Domain | SEA | 3.66e-03 | 14 | 122 | 2 | SM00200 | |
| Domain | RasGAP_CS | 3.66e-03 | 14 | 122 | 2 | IPR023152 | |
| Domain | - | 3.80e-03 | 48 | 122 | 3 | 2.120.10.80 | |
| Domain | RasGAP | 4.20e-03 | 15 | 122 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 4.20e-03 | 15 | 122 | 2 | PS00509 | |
| Domain | - | 4.20e-03 | 15 | 122 | 2 | 3.30.70.960 | |
| Domain | - | 4.20e-03 | 15 | 122 | 2 | 1.10.1000.11 | |
| Domain | RAS_GTPASE_ACTIV_2 | 4.20e-03 | 15 | 122 | 2 | PS50018 | |
| Domain | Sec7 | 4.20e-03 | 15 | 122 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 4.20e-03 | 15 | 122 | 2 | IPR023394 | |
| Domain | 7tm_2 | 4.26e-03 | 50 | 122 | 3 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 4.26e-03 | 50 | 122 | 3 | PS00650 | |
| Domain | WD40_repeat_CS | 4.46e-03 | 164 | 122 | 5 | IPR019775 | |
| Domain | SEC7 | 4.78e-03 | 16 | 122 | 2 | PS50190 | |
| Domain | Nicotinic_acetylcholine_rcpt | 4.78e-03 | 16 | 122 | 2 | IPR002394 | |
| Domain | Sec7 | 4.78e-03 | 16 | 122 | 2 | SM00222 | |
| Domain | Sec7_dom | 4.78e-03 | 16 | 122 | 2 | IPR000904 | |
| Domain | Quinoprotein_ADH-like_supfam | 5.02e-03 | 53 | 122 | 3 | IPR011047 | |
| Domain | - | 5.16e-03 | 321 | 122 | 7 | 3.80.10.10 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.93e-08 | 18 | 79 | 5 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.74e-06 | 40 | 79 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.11e-06 | 41 | 79 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 3.52e-06 | 42 | 79 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 3.96e-06 | 43 | 79 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 6.20e-06 | 47 | 79 | 5 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 7.65e-06 | 49 | 79 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 8.46e-06 | 50 | 79 | 5 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 9.34e-06 | 51 | 79 | 5 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.36e-05 | 55 | 79 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.77e-05 | 58 | 79 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.77e-05 | 58 | 79 | 5 | MM14736 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 2.00e-05 | 100 | 79 | 6 | MM14561 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.24e-05 | 30 | 79 | 4 | M18193 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.92e-05 | 32 | 79 | 4 | MM15143 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.09e-05 | 65 | 79 | 5 | MM15147 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 4.88e-05 | 117 | 79 | 6 | MM15387 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 5.42e-05 | 73 | 79 | 5 | MM14948 | |
| Pathway | WP_RAS_SIGNALING | 7.56e-05 | 184 | 79 | 7 | M39764 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 8.41e-05 | 129 | 79 | 6 | MM14894 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 9.47e-05 | 82 | 79 | 5 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.06e-04 | 84 | 79 | 5 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.19e-04 | 86 | 79 | 5 | MM15413 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.37e-04 | 141 | 79 | 6 | MM15266 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 1.54e-04 | 19 | 79 | 3 | MM15021 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 1.54e-04 | 19 | 79 | 3 | M926 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.54e-04 | 144 | 79 | 6 | MM14501 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.63e-04 | 92 | 79 | 5 | MM14951 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 1.80e-04 | 20 | 79 | 3 | MM15572 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 1.80e-04 | 20 | 79 | 3 | M27853 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.81e-04 | 94 | 79 | 5 | M797 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 2.09e-04 | 21 | 79 | 3 | M27409 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 2.09e-04 | 21 | 79 | 3 | MM15159 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 2.42e-04 | 22 | 79 | 3 | MM15016 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 2.42e-04 | 22 | 79 | 3 | M841 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 2.77e-04 | 23 | 79 | 3 | MM15033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY | 2.77e-04 | 23 | 79 | 3 | M47549 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 3.15e-04 | 24 | 79 | 3 | M13115 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 3.15e-04 | 24 | 79 | 3 | MM15088 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 3.15e-04 | 24 | 79 | 3 | M18308 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 3.15e-04 | 24 | 79 | 3 | M47460 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 3.15e-04 | 24 | 79 | 3 | MM14794 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 3.51e-04 | 60 | 79 | 4 | MM14964 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 3.56e-04 | 25 | 79 | 3 | MM15056 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 3.56e-04 | 25 | 79 | 3 | M811 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 3.56e-04 | 25 | 79 | 3 | M14301 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 4.01e-04 | 26 | 79 | 3 | MM15017 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 4.01e-04 | 26 | 79 | 3 | M47561 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 4.01e-04 | 26 | 79 | 3 | M47562 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 4.01e-04 | 26 | 79 | 3 | M47557 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 4.01e-04 | 26 | 79 | 3 | M47456 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 4.43e-04 | 114 | 79 | 5 | MM15361 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY | 4.50e-04 | 27 | 79 | 3 | M47454 | |
| Pathway | REACTOME_GPER1_SIGNALING | 4.50e-04 | 27 | 79 | 3 | MM15664 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 5.02e-04 | 28 | 79 | 3 | M10679 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY | 5.57e-04 | 29 | 79 | 3 | M47466 | |
| Pathway | PID_RAS_PATHWAY | 6.17e-04 | 30 | 79 | 3 | M269 | |
| Pathway | REACTOME_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS | 6.17e-04 | 30 | 79 | 3 | MM14542 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 6.80e-04 | 31 | 79 | 3 | MM15094 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 6.80e-04 | 31 | 79 | 3 | M47554 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY | 6.80e-04 | 31 | 79 | 3 | M47455 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY | 6.80e-04 | 31 | 79 | 3 | M47459 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 6.80e-04 | 31 | 79 | 3 | M47540 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 6.80e-04 | 31 | 79 | 3 | M47541 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 7.39e-04 | 193 | 79 | 6 | MM14890 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 7.47e-04 | 32 | 79 | 3 | M861 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 7.47e-04 | 32 | 79 | 3 | M14309 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 7.47e-04 | 32 | 79 | 3 | MM15148 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY | 7.47e-04 | 32 | 79 | 3 | M47962 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 7.47e-04 | 32 | 79 | 3 | MM14983 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 8.19e-04 | 33 | 79 | 3 | MM15027 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 8.19e-04 | 33 | 79 | 3 | MM15020 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 8.19e-04 | 33 | 79 | 3 | MM15058 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY | 8.19e-04 | 33 | 79 | 3 | M47550 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 8.19e-04 | 33 | 79 | 3 | MM15066 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 8.19e-04 | 33 | 79 | 3 | M10322 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 8.19e-04 | 33 | 79 | 3 | M9379 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 8.63e-04 | 76 | 79 | 4 | MM15051 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 9.07e-04 | 77 | 79 | 4 | MM15044 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 9.37e-04 | 202 | 79 | 6 | MM15362 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 ARHGAP32 RANBP2 RGPD8 ERCC6L DOCK11 SPTAN1 OBSCN RGPD1 ARHGAP39 RGPD3 | 9.44e-04 | 649 | 79 | 11 | MM15690 |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 9.74e-04 | 35 | 79 | 3 | M1075 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.01e-03 | 205 | 79 | 6 | M752 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 1.05e-03 | 80 | 79 | 4 | M800 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 1.06e-03 | 36 | 79 | 3 | MM14544 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.09e-03 | 9 | 79 | 2 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.09e-03 | 9 | 79 | 2 | MM15313 | |
| Pathway | REACTOME_CHYLOMICRON_REMODELING | 1.09e-03 | 9 | 79 | 2 | MM15563 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.17e-03 | 211 | 79 | 6 | MM14502 | |
| Pathway | REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING | 1.24e-03 | 38 | 79 | 3 | M27656 | |
| Pathway | REACTOME_CHAPERONIN_MEDIATED_PROTEIN_FOLDING | 1.34e-03 | 39 | 79 | 3 | MM15003 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | 1.36e-03 | 10 | 79 | 2 | MM14644 | |
| Pathway | WP_LIPID_PARTICLES_COMPOSITION | 1.36e-03 | 10 | 79 | 2 | M39697 | |
| Pathway | REACTOME_CHYLOMICRON_REMODELING | 1.36e-03 | 10 | 79 | 2 | M27843 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.37e-03 | 86 | 79 | 4 | M916 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 1.44e-03 | 40 | 79 | 3 | MM15115 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.65e-03 | 11 | 79 | 2 | M883 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | 1.65e-03 | 11 | 79 | 2 | M655 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.66e-03 | 42 | 79 | 3 | M791 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.78e-03 | 43 | 79 | 3 | M29837 | |
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.20e-11 | 7 | 126 | 5 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.20e-11 | 7 | 126 | 5 | 11353387 | |
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 30944974 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.20e-11 | 7 | 126 | 5 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.20e-11 | 7 | 126 | 5 | 17372272 | |
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 38657106 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 21205196 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 18949001 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 25187515 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 8603673 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 26632511 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 24403063 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 23818861 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 23536549 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 12191015 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 22821000 | ||
| Pubmed | 1.20e-11 | 7 | 126 | 5 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 3.20e-11 | 8 | 126 | 5 | 21670213 | |
| Pubmed | 3.20e-11 | 8 | 126 | 5 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 3.20e-11 | 8 | 126 | 5 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 3.20e-11 | 8 | 126 | 5 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 3.20e-11 | 8 | 126 | 5 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 7.18e-11 | 9 | 126 | 5 | 18394993 | |
| Pubmed | 7.18e-11 | 9 | 126 | 5 | 28100513 | ||
| Pubmed | 7.18e-11 | 9 | 126 | 5 | 17887960 | ||
| Pubmed | 7.18e-11 | 9 | 126 | 5 | 11553612 | ||
| Pubmed | 7.18e-11 | 9 | 126 | 5 | 10601307 | ||
| Pubmed | 7.18e-11 | 9 | 126 | 5 | 9733766 | ||
| Pubmed | 7.18e-11 | 9 | 126 | 5 | 28877029 | ||
| Pubmed | 1.43e-10 | 10 | 126 | 5 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.43e-10 | 10 | 126 | 5 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.43e-10 | 10 | 126 | 5 | 8857542 | |
| Pubmed | 1.43e-10 | 10 | 126 | 5 | 21859863 | ||
| Pubmed | 2.62e-10 | 11 | 126 | 5 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 2.62e-10 | 11 | 126 | 5 | 35771867 | |
| Pubmed | 2.62e-10 | 11 | 126 | 5 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 7.24e-10 | 13 | 126 | 5 | 31427429 | |
| Pubmed | 1.68e-09 | 15 | 126 | 5 | 14697343 | ||
| Pubmed | RGPD4 ARHGAP32 RANBP2 DMXL2 RGPD8 KDM5A DOCK11 SPTAN1 RGPD1 ADGRB2 ARHGAP39 EDC4 SYNGAP1 NF1 KLHL7 PI4KA RGPD3 ANKRD17 PCNT | 2.08e-09 | 963 | 126 | 19 | 28671696 | |
| Pubmed | 1.44e-08 | 22 | 126 | 5 | 27717094 | ||
| Pubmed | 1.85e-07 | 4 | 126 | 3 | 9480752 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 2.63e-07 | 38 | 126 | 5 | 12791264 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ARHGAP32 ERCC6L KDM5A DOCK11 STXBP4 SPTAN1 EDC4 DNAH7 USP31 MTMR4 NF1 PI4KA ANKRD17 RGL2 DOP1A | 5.72e-07 | 861 | 126 | 15 | 36931259 |
| Pubmed | RGPD4 ARHGAP32 RANBP2 DMXL2 RGPD8 SPTAN1 RGPD1 ADGRB2 ARHGAP39 EDC4 SYNGAP1 NF1 CADPS PI4KA RGPD3 GNB5 NAV3 | 8.20e-07 | 1139 | 126 | 17 | 36417873 | |
| Pubmed | 9.21e-07 | 6 | 126 | 3 | 16884933 | ||
| Pubmed | 1.26e-06 | 215 | 126 | 8 | 35973513 | ||
| Pubmed | 2.68e-06 | 60 | 126 | 5 | 12082592 | ||
| Pubmed | RGPD4 RANBP2 RGPD8 KDM5A RGPD1 RGPD3 ANKRD17 LRBA L3MBTL3 PCNT | 3.15e-06 | 418 | 126 | 10 | 34709266 | |
| Pubmed | 3.84e-06 | 9 | 126 | 3 | 10339615 | ||
| Pubmed | 3.84e-06 | 9 | 126 | 3 | 12615788 | ||
| Pubmed | 5.47e-06 | 10 | 126 | 3 | 14706682 | ||
| Pubmed | Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex. | 5.47e-06 | 10 | 126 | 3 | 28334111 | |
| Pubmed | 5.47e-06 | 10 | 126 | 3 | 9733924 | ||
| Pubmed | 7.50e-06 | 11 | 126 | 3 | 10644457 | ||
| Pubmed | A Non-Canonical Function of Gβ as a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation. | 7.50e-06 | 11 | 126 | 3 | 25982117 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ARHGAP32 ERCC6L ARFGEF2 ARFGEF1 ABCC5 APOB ITGA3 NF1 PI4KA LRBA PCDH18 | 7.61e-06 | 569 | 126 | 11 | 30639242 |
| Pubmed | 7.88e-06 | 35 | 126 | 4 | 18513389 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 9.06e-06 | 281 | 126 | 8 | 28706196 | |
| Pubmed | Neural tube defects and impaired neural progenitor cell proliferation in Gbeta1-deficient mice. | 9.97e-06 | 12 | 126 | 3 | 20186915 | |
| Pubmed | Differential sensitivity of P-Rex1 to isoforms of G protein betagamma dimers. | 9.97e-06 | 12 | 126 | 3 | 16301321 | |
| Pubmed | 9.97e-06 | 12 | 126 | 3 | 8636150 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.03e-05 | 135 | 126 | 6 | 31077711 | |
| Pubmed | Genetic influences on blood pressure within the Stanislas Cohort. | 1.29e-05 | 13 | 126 | 3 | 15076187 | |
| Pubmed | The environmental and genetic evidence for the association of hyperlipidemia and hypertension. | 1.29e-05 | 13 | 126 | 3 | 19155782 | |
| Pubmed | Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes. | 1.30e-05 | 2 | 126 | 2 | 16419488 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 26599105 | ||
| Pubmed | The molecular basis of factor V and VIII procofactor activation. | 1.30e-05 | 2 | 126 | 2 | 19765210 | |
| Pubmed | SOX9-mediated upregulation of LGR5 is important for glioblastoma tumorigenicity. | 1.30e-05 | 2 | 126 | 2 | 25770425 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 14634011 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 28057741 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 15735794 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 10705993 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 28057529 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 23918382 | ||
| Pubmed | Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism. | 1.30e-05 | 2 | 126 | 2 | 17287628 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 17360629 | ||
| Pubmed | RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia. | 1.30e-05 | 2 | 126 | 2 | 24613277 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 10716990 | ||
| Pubmed | Neuronal leucine-rich repeat 1 negatively regulates anaplastic lymphoma kinase in neuroblastoma. | 1.30e-05 | 2 | 126 | 2 | 27604320 | |
| Pubmed | Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma. | 1.30e-05 | 2 | 126 | 2 | 22962301 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 25833958 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18203920 | ||
| Pubmed | Activated protein C has a regulatory role in factor VIII function. | 1.30e-05 | 2 | 126 | 2 | 33512448 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 12670940 | ||
| Pubmed | Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers. | 1.30e-05 | 2 | 126 | 2 | 11091190 | |
| Pubmed | Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma. | 1.30e-05 | 2 | 126 | 2 | 24470379 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 18417613 | ||
| Pubmed | Neuronal GAP-Porf-2 transduces EphB1 signaling to brake axon growth. | 1.30e-05 | 2 | 126 | 2 | 29938386 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 20099167 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 16162496 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 22613792 | ||
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 28629962 | ||
| Pubmed | Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes. | 1.30e-05 | 2 | 126 | 2 | 16989840 | |
| Pubmed | 1.30e-05 | 2 | 126 | 2 | 10212200 | ||
| Pubmed | ARHGAP32 DMXL2 LRRN1 ARHGAP39 SHROOM4 FIG4 RASGRP3 KDM2A PCDH18 DOP1A | 1.33e-05 | 493 | 126 | 10 | 15368895 | |
| Pubmed | 1.59e-05 | 86 | 126 | 5 | 37253089 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.61e-05 | 146 | 126 | 6 | 23892456 | |
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 1.61e-05 | 146 | 126 | 6 | 20686565 | |
| Interaction | RGPD4 interactions | 2.85e-09 | 22 | 121 | 6 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 1.10e-08 | 27 | 121 | 6 | int:RGPD2 | |
| Interaction | RGPD1 interactions | 1.65e-08 | 49 | 121 | 7 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 3.05e-07 | 74 | 121 | 7 | int:RGPD8 | |
| Interaction | RGPD3 interactions | 3.63e-07 | 47 | 121 | 6 | int:RGPD3 | |
| Interaction | RGPD5 interactions | 1.81e-06 | 96 | 121 | 7 | int:RGPD5 | |
| Interaction | NPIPB6 interactions | 3.54e-06 | 18 | 121 | 4 | int:NPIPB6 | |
| Interaction | GNG4 interactions | 1.42e-05 | 25 | 121 | 4 | int:GNG4 | |
| Interaction | GNGT1 interactions | 1.67e-05 | 26 | 121 | 4 | int:GNGT1 | |
| GeneFamily | WD repeat domain containing | 7.27e-08 | 262 | 90 | 11 | 362 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.34e-05 | 115 | 90 | 6 | 769 | |
| GeneFamily | Myb/SANT domain containing|Shelterin complex | 3.63e-04 | 6 | 90 | 2 | 1334 | |
| GeneFamily | Fibronectin type III domain containing | 1.22e-03 | 160 | 90 | 5 | 555 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 2.81e-03 | 16 | 90 | 2 | 173 | |
| GeneFamily | Dyneins, axonemal | 3.17e-03 | 17 | 90 | 2 | 536 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.97e-03 | 19 | 90 | 2 | 50 | |
| GeneFamily | Apolipoproteins | 4.84e-03 | 21 | 90 | 2 | 405 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 5.05e-07 | 33 | 126 | 5 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.97e-06 | 43 | 126 | 5 | MM3857 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.06e-07 | 200 | 126 | 8 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 7.37e-07 | 177 | 126 | 7 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.95e-07 | 179 | 126 | 7 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 9.91e-07 | 185 | 126 | 7 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 1.14e-06 | 189 | 126 | 7 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-06 | 191 | 126 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-06 | 191 | 126 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-06 | 191 | 126 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 1.27e-06 | 192 | 126 | 7 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | distal-Epithelial-Proximal_Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.41e-06 | 195 | 126 | 7 | abe7998421dc59bdae35c0c2251c4a1ebef5e021 | |
| ToppCell | distal-Epithelial-Proximal_Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.41e-06 | 195 | 126 | 7 | 0e3f74e0877d33c11f048b9be8394596cf5c9c4c | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 1.46e-06 | 196 | 126 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.51e-06 | 197 | 126 | 7 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.72e-06 | 157 | 126 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | Ciliated_cells-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 9.02e-06 | 170 | 126 | 6 | 3d3a03979014df3a05c49be18010c6b94d786707 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.96e-06 | 173 | 126 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 179 | 126 | 6 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.25e-05 | 180 | 126 | 6 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-05 | 181 | 126 | 6 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-05 | 182 | 126 | 6 | 975f6275777fc578eba528e50f69891c66ec44ad | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-05 | 182 | 126 | 6 | f8c28fa76751062c4cfba0db8af1b377f947f739 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 183 | 126 | 6 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-05 | 183 | 126 | 6 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-05 | 184 | 126 | 6 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-05 | 185 | 126 | 6 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | Ciliated_cells-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-05 | 185 | 126 | 6 | d77ca57b02125a3a57a37f4aed20c89803b7d551 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-05 | 185 | 126 | 6 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 126 | 6 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 126 | 6 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 186 | 126 | 6 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | 18-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 1.55e-05 | 187 | 126 | 6 | 8d7fa6b2950898e7f283401808378ba2a41b9651 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 1.55e-05 | 187 | 126 | 6 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.55e-05 | 187 | 126 | 6 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.55e-05 | 187 | 126 | 6 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 1.60e-05 | 188 | 126 | 6 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-05 | 188 | 126 | 6 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-05 | 188 | 126 | 6 | 82c006f43c93f4a867953a446864f02b44536a23 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-05 | 188 | 126 | 6 | da59b5c0a4b11690a39a964c1a0a83e66aa0972b | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.60e-05 | 188 | 126 | 6 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.60e-05 | 188 | 126 | 6 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.60e-05 | 188 | 126 | 6 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.65e-05 | 189 | 126 | 6 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 1.65e-05 | 189 | 126 | 6 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 190 | 126 | 6 | 169e600e95878000acf5d11f813f9028c7249646 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 190 | 126 | 6 | 0cc36117c793d83cf4a1f66f47758a07d6712bd3 | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.70e-05 | 190 | 126 | 6 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 190 | 126 | 6 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-05 | 190 | 126 | 6 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.70e-05 | 190 | 126 | 6 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.70e-05 | 190 | 126 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-05 | 190 | 126 | 6 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.70e-05 | 190 | 126 | 6 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 190 | 126 | 6 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-05 | 190 | 126 | 6 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 190 | 126 | 6 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.75e-05 | 191 | 126 | 6 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-05 | 191 | 126 | 6 | 8a5a2188b13ef4bbfd626a42565566708a751c1b | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-05 | 191 | 126 | 6 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.75e-05 | 191 | 126 | 6 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-05 | 191 | 126 | 6 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-05 | 191 | 126 | 6 | e314dd8f1a841cab847ae3703bedfe1bc623ac61 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.75e-05 | 191 | 126 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30） | 1.75e-05 | 191 | 126 | 6 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.80e-05 | 192 | 126 | 6 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.85e-05 | 193 | 126 | 6 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.85e-05 | 193 | 126 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.85e-05 | 193 | 126 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.85e-05 | 193 | 126 | 6 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.85e-05 | 193 | 126 | 6 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.91e-05 | 194 | 126 | 6 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.91e-05 | 194 | 126 | 6 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.91e-05 | 194 | 126 | 6 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-05 | 194 | 126 | 6 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 1.91e-05 | 194 | 126 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-05 | 195 | 126 | 6 | d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 195 | 126 | 6 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-05 | 195 | 126 | 6 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.96e-05 | 195 | 126 | 6 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 195 | 126 | 6 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 195 | 126 | 6 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-05 | 195 | 126 | 6 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 1.96e-05 | 195 | 126 | 6 | 3441381759cd00d125752401dc99b78be1c78f88 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 195 | 126 | 6 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.96e-05 | 195 | 126 | 6 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-05 | 195 | 126 | 6 | e7f069f557a59ee7b502ff82ad4c9f47fa619ba8 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-05 | 196 | 126 | 6 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.02e-05 | 196 | 126 | 6 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.02e-05 | 196 | 126 | 6 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.02e-05 | 196 | 126 | 6 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.02e-05 | 196 | 126 | 6 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 2.08e-05 | 197 | 126 | 6 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.08e-05 | 197 | 126 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | proximal-Epithelial-Proximal_Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-05 | 198 | 126 | 6 | 69acfdd525c05483f496e54f36762fcbc5521bd4 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.14e-05 | 198 | 126 | 6 | 16c54b884500066ade05a406915f9569ca8abdfc | |
| ToppCell | proximal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-05 | 198 | 126 | 6 | 090e2895f1fb37473d5212b2bed31c15b0745dc4 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-05 | 198 | 126 | 6 | d7e15e61b6018e4c36461c9471ee29601929925c | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 2.14e-05 | 198 | 126 | 6 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | proximal-Epithelial-Proximal_Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.14e-05 | 198 | 126 | 6 | 594b46e811f112d98879b59fdd0cfb068fc07f94 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.20e-05 | 199 | 126 | 6 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.20e-05 | 199 | 126 | 6 | b974b495cabbcc3934936cec846c0e2442a70ac3 | |
| Disease | Colorectal Carcinoma | CPAMD8 OBSCN IPP ARFGEF1 ABCC5 APOB LGR5 F5 NF1 SLCO2A1 GNB5 KDM2A GNB4 NLRP8 | 1.07e-06 | 702 | 120 | 14 | C0009402 |
| Disease | familial hyperlipidemia (is_implicated_in) | 3.62e-06 | 8 | 120 | 3 | DOID:1168 (is_implicated_in) | |
| Disease | Granuloma, Plasma Cell | 1.64e-05 | 2 | 120 | 2 | C0018199 | |
| Disease | Colorectal Neoplasms | 1.85e-05 | 277 | 120 | 8 | C0009404 | |
| Disease | peripheral arterial disease | 7.03e-05 | 54 | 120 | 4 | EFO_0004265 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 8.53e-05 | 109 | 120 | 5 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 8.91e-05 | 110 | 120 | 5 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 8.91e-05 | 110 | 120 | 5 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 8.91e-05 | 110 | 120 | 5 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | Malignant neoplasm of breast | AMFR STXBP4 SPTAN1 OBSCN LDHAL6B ARFGEF2 EDNRA C5orf34 NF1 LRBA L3MBTL3 ALK DOP1A NLRP8 | 1.22e-04 | 1074 | 120 | 14 | C0006142 |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.03e-04 | 206 | 120 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | very low density lipoprotein particle size measurement | 2.17e-04 | 133 | 120 | 5 | EFO_0008594 | |
| Disease | viral load | 2.41e-04 | 136 | 120 | 5 | EFO_0010125 | |
| Disease | Inflammatory Myofibroblastic Tumor | 2.43e-04 | 6 | 120 | 2 | C0334121 | |
| Disease | Schizophrenia | ARHGAP32 GRIK1 CHRNA3 SYNGAP1 ADAMTS12 EML5 PI4KA LPL TAAR1 GNB3 ALK PCNT | 2.62e-04 | 883 | 120 | 12 | C0036341 |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 2.71e-04 | 31 | 120 | 3 | EFO_0022249 | |
| Disease | stomach cancer (is_marker_for) | 2.94e-04 | 142 | 120 | 5 | DOID:10534 (is_marker_for) | |
| Disease | triglyceride measurement, phospholipid measurement | 3.34e-04 | 146 | 120 | 5 | EFO_0004530, EFO_0004639 | |
| Disease | lung carcinoma (is_implicated_in) | 3.40e-04 | 7 | 120 | 2 | DOID:3905 (is_implicated_in) | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 4.52e-04 | 8 | 120 | 2 | EFO_0800533 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 4.90e-04 | 243 | 120 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 6.23e-04 | 95 | 120 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 6.48e-04 | 96 | 120 | 4 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | triglycerides in large LDL measurement | 7.19e-04 | 43 | 120 | 3 | EFO_0022319 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 7.23e-04 | 10 | 120 | 2 | OBA_2045163 | |
| Disease | total lipids in very small VLDL measurement | 8.22e-04 | 45 | 120 | 3 | EFO_0022156 | |
| Disease | saturated fatty acids measurement | 8.22e-04 | 45 | 120 | 3 | EFO_0022304 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 8.43e-04 | 103 | 120 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | Familial Atypical Mole Melanoma Syndrome | 8.81e-04 | 11 | 120 | 2 | C2314896 | |
| Disease | cocaine use | 8.81e-04 | 11 | 120 | 2 | C3496069 | |
| Disease | free cholesterol in small VLDL measurement | 9.33e-04 | 47 | 120 | 3 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 9.33e-04 | 47 | 120 | 3 | EFO_0022275 | |
| Disease | free cholesterol in medium VLDL measurement | 9.33e-04 | 47 | 120 | 3 | EFO_0022269 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 9.39e-04 | 106 | 120 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 1.05e-03 | 12 | 120 | 2 | C1861063 | |
| Disease | integral membrane protein 2B measurement | 1.05e-03 | 12 | 120 | 2 | EFO_0802634 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 1.05e-03 | 49 | 120 | 3 | EFO_0021897 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 1.11e-03 | 111 | 120 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | free cholesterol in LDL measurement | 1.12e-03 | 50 | 120 | 3 | EFO_0022266 | |
| Disease | phospholipids in very small VLDL measurement | 1.18e-03 | 51 | 120 | 3 | EFO_0022300 | |
| Disease | Hyperlipoproteinemia Type IIb | 1.24e-03 | 13 | 120 | 2 | C1704417 | |
| Disease | phospholipids in medium VLDL measurement | 1.25e-03 | 52 | 120 | 3 | EFO_0022154 | |
| Disease | cholesterol in small VLDL measurement | 1.32e-03 | 53 | 120 | 3 | EFO_0022228 | |
| Disease | free cholesterol in small LDL measurement | 1.32e-03 | 53 | 120 | 3 | EFO_0022271 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 1.40e-03 | 118 | 120 | 4 | EFO_0010119 | |
| Disease | total lipids in medium VLDL | 1.40e-03 | 54 | 120 | 3 | EFO_0022153 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.45e-03 | 14 | 120 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | triglycerides in medium VLDL measurement | 1.48e-03 | 55 | 120 | 3 | EFO_0022155 | |
| Disease | Antithrombotic agent use measurement | 1.48e-03 | 55 | 120 | 3 | EFO_0009925 | |
| Disease | triglycerides in very large HDL measurement | 1.48e-03 | 55 | 120 | 3 | EFO_0022324 | |
| Disease | hypertension (is_implicated_in) | 1.53e-03 | 121 | 120 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | triglycerides in large VLDL measurement | 1.55e-03 | 56 | 120 | 3 | EFO_0022178 | |
| Disease | ovarian cancer (is_implicated_in) | 1.55e-03 | 56 | 120 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | triglycerides in LDL measurement | 1.55e-03 | 56 | 120 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 1.55e-03 | 56 | 120 | 3 | EFO_0022325 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 1.55e-03 | 56 | 120 | 3 | EFO_0022316 | |
| Disease | low density lipoprotein triglyceride measurement | 1.66e-03 | 15 | 120 | 2 | EFO_0009946 | |
| Disease | triacylglycerol 52:3 measurement | 1.66e-03 | 15 | 120 | 2 | EFO_0010415 | |
| Disease | Hypertriglyceridemia | 1.66e-03 | 15 | 120 | 2 | C0020557 | |
| Disease | hepcidin:transferrin saturation ratio | 1.66e-03 | 15 | 120 | 2 | EFO_0007902 | |
| Disease | triglycerides in IDL measurement | 1.72e-03 | 58 | 120 | 3 | EFO_0022149 | |
| Disease | triglycerides in VLDL measurement | 1.81e-03 | 59 | 120 | 3 | EFO_0022326 | |
| Disease | phospholipids in VLDL measurement | 1.81e-03 | 59 | 120 | 3 | EFO_0022301 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 1.81e-03 | 59 | 120 | 3 | EFO_0022260 | |
| Disease | esterified cholesterol measurement | 1.88e-03 | 128 | 120 | 4 | EFO_0008589 | |
| Disease | phospholipids in small VLDL measurement | 1.90e-03 | 60 | 120 | 3 | EFO_0022146 | |
| Disease | total lipids in IDL | 1.90e-03 | 60 | 120 | 3 | EFO_0022161 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 1.90e-03 | 60 | 120 | 3 | EFO_0021898 | |
| Disease | total lipids in VLDL measurement | 1.90e-03 | 60 | 120 | 3 | EFO_0022314 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.90e-03 | 215 | 120 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | Hyperlipoproteinemia Type IIa | 1.90e-03 | 16 | 120 | 2 | C0745103 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.90e-03 | 16 | 120 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | triglycerides in small VLDL measurement | 1.99e-03 | 61 | 120 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 1.99e-03 | 61 | 120 | 3 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 1.99e-03 | 61 | 120 | 3 | EFO_0022276 | |
| Disease | phospholipids in large VLDL measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0022322 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0022306 | |
| Disease | total lipids in very large VLDL measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0022313 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0022263 | |
| Disease | phospholipids in very large VLDL measurement | 2.08e-03 | 62 | 120 | 3 | EFO_0022299 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.10e-03 | 220 | 120 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | Lipidemias | 2.14e-03 | 17 | 120 | 2 | C1706412 | |
| Disease | Moyamoya Disease | 2.14e-03 | 17 | 120 | 2 | C0026654 | |
| Disease | Hyperlipidemia | 2.14e-03 | 17 | 120 | 2 | C0020473 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 2.18e-03 | 63 | 120 | 3 | EFO_0022292 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.27e-03 | 224 | 120 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.27e-03 | 224 | 120 | 5 | EFO_0004574, EFO_0008317 | |
| Disease | triglycerides in small LDL measurement | 2.38e-03 | 65 | 120 | 3 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 2.38e-03 | 65 | 120 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 2.38e-03 | 65 | 120 | 3 | EFO_0022230 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 2.40e-03 | 18 | 120 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | Hypercholesterolemia, Familial | 2.40e-03 | 18 | 120 | 2 | C0020445 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 2.41e-03 | 137 | 120 | 4 | EFO_0004611, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.49e-03 | 229 | 120 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | Profound Mental Retardation | 2.54e-03 | 139 | 120 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.54e-03 | 139 | 120 | 4 | C0025363 | |
| Disease | Mental deficiency | 2.54e-03 | 139 | 120 | 4 | C0917816 | |
| Disease | total lipids in small VLDL | 2.60e-03 | 67 | 120 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 2.60e-03 | 67 | 120 | 3 | EFO_0022175 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HQSWSTFKSMTLGSL | 1541 | O60241 | |
| CTHTTWSGNIMTKTL | 31 | Q14264 | |
| WSMSLGIKHPVTHVS | 126 | Q86XM0 | |
| RTPTTHTMPSWVKTV | 331 | P32297 | |
| MASTKLSPWDKSSHS | 851 | Q6QNK2 | |
| ETSTSSFDHKWMVIQ | 536 | Q9Y6D6 | |
| DNPHVSSIIEKWSME | 286 | P39086 | |
| LSEKSEWMTTTCNHA | 1391 | Q9Y6D5 | |
| WSILHQADSSEKMTI | 1776 | Q5JWR5 | |
| TSVPMNGTSIQWKNH | 396 | P25101 | |
| CKTSVSVHLMEWSPD | 166 | Q8TDJ6 | |
| MSVDTVSWNPYHTKV | 541 | Q9UI46 | |
| KWTVTTFSTTPHMPT | 291 | Q6Q4G3 | |
| ATIKNIMDSWTHQSG | 561 | Q6Q4G3 | |
| AADPSWNSLIKMVSS | 2561 | O75179 | |
| LHSPTEKMITCVSWH | 331 | Q8IWG1 | |
| AAHITMKTNPFVWSS | 421 | Q9H324 | |
| DWTKRPTSTMSCNEH | 1456 | P58397 | |
| LTWQSRTQDEHPKTM | 176 | Q9UBL3 | |
| WVTSYKVMVSNDSHT | 221 | Q8N436 | |
| YMPSTHRTTEKWNSV | 161 | P55895 | |
| NHWITTTMNLKPLSG | 2086 | P49792 | |
| HWITTTMNLKPLSGS | 1111 | Q99666 | |
| HWITTTMNLKPLSGS | 1111 | O14715 | |
| AWSSESIKKPMIVTS | 721 | Q9C0H5 | |
| MLRSSHSTWPVDVSQ | 271 | Q6P2E9 | |
| TTNKEHAVTMPCTWV | 136 | O14775 | |
| VTKQWTTVASMNHPR | 366 | Q9Y573 | |
| HSSVQPSSKWLPAME | 1076 | Q9HCL0 | |
| KKATATTTWMVPTAQ | 56 | Q96JM7 | |
| TKIISLSHLEMTWTN | 216 | Q6NSI4 | |
| SPIWTSETHEKLSQM | 86 | Q5VTT2 | |
| PNSPKQSEWHKMTVS | 486 | Q9ULU8 | |
| DTTGLHQKTSLWTMS | 6 | Q9Y442 | |
| HQVSATMRSITLSWP | 441 | P54762 | |
| STMILEVVKNSVHSW | 361 | Q9NVI1 | |
| PQHTQWVETSPSMKT | 531 | Q8WXI7 | |
| KHANETSLSIMWQTP | 476 | P23467 | |
| SWPHSNVLDISMLSS | 1306 | Q71F56 | |
| FMNVWKLSSSSHPGS | 666 | Q86W28 | |
| KAMTQNITGHTSWTT | 371 | Q99665 | |
| RHPWVVSMAASSSMK | 351 | P11801 | |
| SIPTINMENKTTWFS | 961 | P26006 | |
| TWLFTPVSKMATVKS | 41 | Q9BYZ2 | |
| HSSKTFMVIHGWTVT | 71 | P06858 | |
| PWRSKSMNVKHSATS | 331 | Q8IVL0 | |
| LSWVKNTVSHTVSQM | 31 | O60447 | |
| QTWTMAPESVLHAKS | 271 | Q32MH5 | |
| QEAMKWAPTVTKSHL | 1066 | P42356 | |
| IETDIQMWRSHSTKT | 1326 | P50851 | |
| PSITTSLVFTVHMWK | 666 | A0A1B0GTW7 | |
| MHWATDSKLLVSASQ | 61 | P16520 | |
| TTNKMHAIPLRSSWV | 86 | Q9HAV0 | |
| STQWSKNMKHLTPST | 1356 | P00451 | |
| TNMFATWSPSKARLH | 2216 | P00451 | |
| RTESWHTKPSMLTQR | 406 | Q8IXQ5 | |
| MDSKDESSHVWPTSA | 1 | Q9NQV6 | |
| TTPATAQMSTKEASW | 1266 | A7KAX9 | |
| AADTKSLWPMASAHL | 2091 | O95613 | |
| IKSEEVVTHMWTAPS | 1381 | P29375 | |
| KWMDSVSSHSPLSKS | 1266 | Q96JM4 | |
| SALESTKWLQHLSVM | 371 | Q9NYA4 | |
| MWLSSHPKQVSSTKP | 981 | Q9NYA4 | |
| SWSSPMAAHLSEDAK | 6681 | Q5VST9 | |
| EMKNATLAWDSSHSS | 491 | O15440 | |
| NHWITTTMNLKPLSG | 1111 | A6NKT7 | |
| SNMDKLLPHSSVLTW | 481 | A4D1B5 | |
| TPTTHTMPRWVKTVF | 331 | Q15825 | |
| WGPQMSASVHLDSKK | 1461 | P04114 | |
| TWEMPDHSLLSTASK | 2561 | Q6WRI0 | |
| LTWKTSIRMPSHNTV | 396 | Q8N6C5 | |
| NMWPRHLKESQTEST | 171 | Q9Y2K7 | |
| WLHKANVNSTITVTM | 171 | Q5JSL3 | |
| APWTQHSKDIMQTLS | 561 | Q92562 | |
| WISTSKMGEPVASAH | 1011 | Q8IZJ3 | |
| SMVSTKPHWQQAAPS | 46 | Q8WXX0 | |
| LPAKWSVSESSPHMA | 456 | Q9H4A9 | |
| PKFLDSMSTSAEWSS | 1061 | Q9ULL0 | |
| TAPSIHIWDAMNKQT | 1446 | Q05BV3 | |
| PSIHIWDAMTKHTLS | 1441 | Q6ZMW3 | |
| SKMKSPDWLCHSSSN | 6871 | Q8NDH2 | |
| EMPTHSSSSVLQENW | 546 | Q96MH7 | |
| DVWCKNESSMPHSVI | 706 | Q7Z3Z3 | |
| LSSENKSSWLMTSKP | 1151 | Q2NKX8 | |
| SHSILVSWKVNSNVM | 536 | Q6UXK5 | |
| WSSATMKIDNPHITY | 556 | Q6UXK5 | |
| WTRSKHPSLMSINSD | 841 | O75473 | |
| HWITTTMNLKPLSGS | 1096 | P0DJD0 | |
| MQKISSTELHVEWSP | 1251 | O75445 | |
| ASVSKSAWTMEALPE | 4431 | O75445 | |
| NHWITTTMNLKPLSG | 1111 | Q7Z3J3 | |
| AQHMKWPSVSSLDSA | 571 | O15211 | |
| MATKNNTSHWIDSTT | 426 | Q7Z5M5 | |
| ESHKISMPLHMSTWI | 271 | Q8TBP6 | |
| SQMSPSSEHEVWQTV | 1171 | P12259 | |
| TPMAGLHQWKTTVSF | 336 | Q86X40 | |
| MPSGSHWTANSSKII | 1 | Q6ZSM3 | |
| SHLSSEVTKNWNEMT | 261 | Q8IV61 | |
| STHMSPSWTLLKLCD | 141 | Q9NUX5 | |
| REMAHSKTSFSWATP | 986 | Q9ULL8 | |
| PSWALHSVMNTHTLS | 161 | Q96SF2 | |
| WSQMKPTHDALQKTT | 1461 | P14410 | |
| ATPASAGHVWMSKQQ | 326 | P48436 | |
| SVHSTEMVSVAWPTE | 871 | Q9BZV3 | |
| NHVTQTTSWIHPVMS | 516 | Q6ZWJ1 | |
| TTSWIHPVMSVLNLS | 521 | Q6ZWJ1 | |
| VQTHKSDWSLATMPT | 46 | O43610 | |
| SADSKHTILSPWMRS | 326 | Q9UM73 | |
| SMTLASFWKPSANIT | 411 | Q14246 | |
| SWLPSFSVEVMHTTN | 431 | Q9UKV5 | |
| SWKINNLMSTVHSDE | 56 | Q9BWW9 | |
| HSTTQNPQKETSSMW | 156 | Q92959 | |
| TMASSILKWVVSHQS | 211 | A6PVC2 | |
| SERTVAWVSNMPHLS | 1151 | Q96PV0 | |
| MPGTVHSSWHSVKQT | 846 | Q6ZQQ2 | |
| HSSWHSVKQTMSLPE | 851 | Q6ZQQ2 | |
| SKTASPWKSARLMVH | 1186 | Q13813 | |
| TSHQMLSSTEILKWL | 586 | P21359 | |
| TPTNWLIHSMATVDF | 56 | Q96RJ0 | |
| SADVSSAWAQHVTKM | 611 | Q99835 | |
| HSNGTVSLWSPAMKE | 336 | O15213 | |
| MAASSISSPWGKHVF | 1 | Q9BVC6 | |
| KNLSSHWLMKSEPES | 51 | Q9P016 | |
| HTWAGMSKPSSKNTE | 271 | Q9H967 | |
| SMNSHLIWPQKSHTG | 376 | Q6ZMW2 | |
| MTPHVVKRSQSSWSL | 671 | Q70CQ4 | |
| SSASSLTMAHVPWHE | 611 | Q9NV66 | |
| SEKKMHSVTPVEISW | 826 | Q86VR7 | |
| PSTSHVSMWKTSDSV | 261 | Q96H15 | |
| WKSMFSDQVLAHPSV | 686 | Q9UBB9 | |
| ESSASSLTMAHVPWH | 546 | Q6NUM6 | |
| AMEKSSLTQHSWQSL | 166 | Q9NYB0 | |
| MSSEKWHQTISLALI | 441 | Q9GZU3 | |
| QDVPSKWSTSFHMLE | 886 | O75132 | |
| KMSPHSLTCVTSSHW | 946 | P23378 |